Posted by Michael Wonder on 07 Aug 2018
The European Medicines Agency: PRIME’d for access?
7 August 2018 - Regulators around the world have been working for decades to speed up access to the best of the new medicines being developed and brought to market.
The EMA is no different offering five routes that can hasten approval, under certain conditions. The most recently added – the PRIority Medicines (PRIME) scheme – reached its two-year anniversary in March 2018.
So how has it gone?
